NO940131D0 - Salts of 4-pyrimidinone derivatives for framasoytic use - Google Patents

Salts of 4-pyrimidinone derivatives for framasoytic use

Info

Publication number
NO940131D0
NO940131D0 NO940131A NO940131A NO940131D0 NO 940131 D0 NO940131 D0 NO 940131D0 NO 940131 A NO940131 A NO 940131A NO 940131 A NO940131 A NO 940131A NO 940131 D0 NO940131 D0 NO 940131D0
Authority
NO
Norway
Prior art keywords
framasoytic
salts
pyrimidinone derivatives
pyrimidinone
derivatives
Prior art date
Application number
NO940131A
Other languages
Norwegian (no)
Other versions
NO940131L (en
Inventor
Christian Hoornaert
Alexander Eduard Wick
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO940131D0 publication Critical patent/NO940131D0/en
Publication of NO940131L publication Critical patent/NO940131L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO940131A 1993-01-15 1994-01-14 Salts of 4-pyrimidinone derivatives for pharmaceutical use NO940131L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9300340A FR2700543B1 (en) 1993-01-15 1993-01-15 Salts of 4-pyrimidinone derivatives, their preparation and their therapeutic use.

Publications (2)

Publication Number Publication Date
NO940131D0 true NO940131D0 (en) 1994-01-14
NO940131L NO940131L (en) 1994-07-18

Family

ID=9443056

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940131A NO940131L (en) 1993-01-15 1994-01-14 Salts of 4-pyrimidinone derivatives for pharmaceutical use

Country Status (16)

Country Link
EP (1) EP0607077A1 (en)
JP (1) JPH06271548A (en)
KR (1) KR940018365A (en)
CN (1) CN1096783A (en)
AU (1) AU5317694A (en)
CA (1) CA2113491A1 (en)
CZ (1) CZ9494A3 (en)
FI (1) FI940185A (en)
FR (1) FR2700543B1 (en)
HU (1) HUT70193A (en)
IL (1) IL108342A0 (en)
NO (1) NO940131L (en)
NZ (1) NZ250678A (en)
PL (1) PL301900A1 (en)
SK (1) SK4794A3 (en)
ZA (1) ZA94290B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990081093A (en) 1998-04-25 1999-11-15 조생현 Pyrimidinone compound, pharmaceutical composition containing the same, and preparation method thereof
GB0914287D0 (en) * 2009-08-14 2009-09-30 Pci Biotech As Compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2672892B1 (en) * 1991-02-20 1994-01-14 Synthelabo DERIVATIVES OF 4-PYRIMIDINONES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION.

Also Published As

Publication number Publication date
HUT70193A (en) 1995-09-28
FR2700543B1 (en) 1995-03-17
EP0607077A1 (en) 1994-07-20
CA2113491A1 (en) 1994-07-16
PL301900A1 (en) 1994-07-25
IL108342A0 (en) 1994-04-12
HU9400108D0 (en) 1994-05-30
FI940185A (en) 1994-07-16
ZA94290B (en) 1994-08-17
NO940131L (en) 1994-07-18
FI940185A0 (en) 1994-01-14
AU5317694A (en) 1994-07-21
FR2700543A1 (en) 1994-07-22
CN1096783A (en) 1994-12-28
CZ9494A3 (en) 1994-08-17
SK4794A3 (en) 1995-01-12
NZ250678A (en) 1994-10-26
KR940018365A (en) 1994-08-16
JPH06271548A (en) 1994-09-27

Similar Documents

Publication Publication Date Title
NO985192D0 (en) Inclusion complexes of aryl-heterocyclic salts
BR9510256A (en) Derivatives of 3-aryl-tetronic acid
NO932127D0 (en) IMIDATE DERIVATIVES OF PHARMASOEYTIC USEFUL ANTICONVULSING SULFAMATES
NO941968L (en) Organic salts of N, N'-diacetylcystine
ATA75293A (en) INDOLDER DERIVATIVES
FI940769A (en) Process for the preparation of 2-aminoazole derivatives
FI954007A (en) Use of substituted 4-phenyl-6-amino-nicotinic acid derivatives as a medicament
DE69330497D1 (en) CHINAZOLIN DERIVATIVES
DE59308714D1 (en) CYCLOBUTANE-BENZENE DERIVATIVES
NO305077B1 (en) Process for the preparation of piperidine derivatives
NO954323D0 (en) Heterocyclic derivatives
FI925172A0 (en) ANORDINATION FOR ADJUSTMENT OF REPAIR I EN VAERMEANORDNING
NO952288D0 (en) Benzazepinon derivatives
DE69313890D1 (en) 5-aminoflavone derivatives
FI973500A (en) Derivatives of 3-pyrrolidylidene-2-one cephalosporins
FI941380A (en) Phenylglycinamides of heterocyclic substituted phenylacetic acid derivatives
NO940131D0 (en) Salts of 4-pyrimidinone derivatives for framasoytic use
NO924151L (en) COMPLEX SALTS OF HEMATOPORPHYRINE, DERIVATIVES THEREOF, PROCEDURE FOR MANUFACTURING AND THERAPEUTIC APPLICATION
NO920272D0 (en) HYDROFILE-HYDROPHOBE DERIVATIVES OF POLYGALACTUMANNANES CONTAINING TERTIAS AMINFUNCTIONALITY
FI971964A (en) Process for the preparation of 1-halo-3-trialkylsilanylbenzene derivatives
BR9306699A (en) Derivatives of triazolylethanol
NO943237L (en) Process for the preparation of benzothiazepine derivatives
NO940417D0 (en) Use of quinolizine derivatives as insensitive agents
LV10277A (en) Derivatives of cephalosporin
NO963084L (en) Process for the preparation of pyrrolidinyl-acetamide derivatives